Researchers find genetic variant contributing to disparities in childhood leukemia risk

by Keck School of Medicine of USCCredit: CC0 Public DomainAcute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in th

Updated on: March 27,2024

Researchers find genetic variant contributing to disparities in childhood leukemia risk

by Keck School of Medicine of USCCredit: CC0 Public DomainAcute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in th

Updated on:March 27,2024

Team of sister scientists identify a possible genetic culprit for uterine corpus endometrial cancer

by Allison Trouten,Medical University of South CarolinaMYO5B mRNA is elevated in uterine corpus endometrial carcinoma (UCEC) patients. A. The expression of MYO5B in various control tissues and t

Updated on: December 26,2023

Team of sister scientists identify a possible genetic culprit for uterine corpus endometrial cancer

by Allison Trouten,Medical University of South CarolinaMYO5B mRNA is elevated in uterine corpus endometrial carcinoma (UCEC) patients. A. The expression of MYO5B in various control tissues and t

Updated on:December 26,2023

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Updated on: December 22,2023

Insurance disparities ID'd in diagnosis of late-stage melanoma

For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance,

Updated on:December 22,2023

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on: January 11,2024

New chemical technology leads to better targeted therapeutics against high-risk leukemia in lab

bySt. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainMore-effective therapies are greatly needed for children with the high-risk blood cancer T-cell acute lymphoblastic l

Updated on:January 11,2024

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on: December 22,2023

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col

Updated on:December 22,2023

Multi-strain probiotic reduces chemotherapy-induced diarrhoea

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA high concentration of multi-strain probiotic helps to reduce mild to moderate episodes of chemotherapy-induced diarrhoea (CID) i

Updated on: December 18,2023

Multi-strain probiotic reduces chemotherapy-induced diarrhoea

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA high concentration of multi-strain probiotic helps to reduce mild to moderate episodes of chemotherapy-induced diarrhoea (CID) i

Updated on:December 18,2023

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024

Denosumab linked to severe hypocalcemia in dialysis-dependent seniors

by Elana GotkineFor female dialysis-dependent patients aged 65 years or older treated for osteoporosis, denosumab is associated with an increased incidence of severe or very severe hypocalcemia, accor

Updated on: March 26,2024

Denosumab linked to severe hypocalcemia in dialysis-dependent seniors

by Elana GotkineFor female dialysis-dependent patients aged 65 years or older treated for osteoporosis, denosumab is associated with an increased incidence of severe or very severe hypocalcemia, accor

Updated on:March 26,2024

Why early treatment of esophageal cancer is critical

by DeeDee Stiepan,Mayo ClinicCredit: Mayo Clinic News NetworkEsophageal cancer, which is cancer that occurs in the esophagus—a long, hollow tube that runs from your throat to your stomach—is on

Updated on: January 08,2024

Why early treatment of esophageal cancer is critical

by DeeDee Stiepan,Mayo ClinicCredit: Mayo Clinic News NetworkEsophageal cancer, which is cancer that occurs in the esophagus—a long, hollow tube that runs from your throat to your stomach—is on

Updated on:January 08,2024

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on: March 20,2024

New AI model detects 90% of lymphatic cancer cases

by Chalmers University of TechnologyCredit:The Lancet Digital Health(2023). DOI: 10.1016/S2589-7500(23)00203-0Medical image analysis using AI has developed rapidly in recent years. No

Updated on:March 20,2024

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,

Updated on: December 22,2023

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,

Updated on:December 22,2023

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present

Updated on: May 05,2024

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present

Updated on:May 05,2024